Sanofi Consumer Healthcare India Limited has fixed Friday, June 19, 2026, as the record date to determine shareholder eligibility for a final dividend of ₹75 per equity share for the financial year ended December 31, 2025. The dividend will be paid on July 9, 2026, to members whose names appear on the Register of Members or as Beneficial Owners on the record date. The announcement was made in the notice for the 3rd Annual General Meeting (AGM) scheduled to be held on June 26, 2026, through Video Conferencing and Other Audio Visual Means.

The AGM will transact ordinary business, including the adoption of the audited standalone financial statements for the year ended December 31, 2025. Shareholders will consider the re-appointment of Mr. Stanislas Camart, a Non-Executive Director who retires by rotation and is eligible for re-appointment. Mr. Camart has served as the CHC Chief Accounting Officer and Head of Global Business Services at Opella since October 2022.

A key agenda item involves the appointment of M/s. Price Waterhouse & Co Chartered Accountants LLP as the Statutory Auditors. The firm was appointed by the Board on May 25, 2026, to fill a casual vacancy caused by the resignation of M/s. Kalyaniwalla & Mistry LLP. Shareholders are asked to approve this appointment effective from May 25, 2026, until the conclusion of the 3rd AGM, and subsequently for a term of five years ending with the 8th AGM in 2031.

The proposed fees for the new auditors include ₹1.20 million for three limited reviews and ₹2.95 million for the statutory audit, excluding out-of-pocket expenses. The Board noted that the fees payable to the new auditors are lower than the fee increase sought by the outgoing auditors. The firm is registered with the Institute of Chartered Accountants of India and is a member firm of Price Waterhouse & Affiliates.

Shareholders will also ratify the remuneration of M/s. Kishore Bhatia & Associates, Cost Accountants, for the audit of cost records for the financial year ending December 31, 2026. The ratified remuneration is ₹3,15,000 plus applicable taxes and reimbursement of out-of-pocket expenses. The Register of Members will remain closed from June 20, 2026, to June 26, 2026.

Key AGM Dates

Sanofi Consumer Healthcare India Limited has filed its Business Responsibility and Sustainability Report (BRSR) for the financial year ended December 31, 2025, with the stock exchanges. The filing, dated June 4, 2026, details the company's environmental, social, and governance (ESG) performance, highlighting a significant transition to renewable energy that resulted in zero Scope 1 and Scope 2 greenhouse gas emissions for the calendar year.

The company reported that it consumed 642.83 GJ of energy from renewable sources in CY 2025, compared to 3,449.09 GJ in the previous year. This shift to green energy at its new leased office premises contributed to the elimination of direct and indirect greenhouse gas emissions, which stood at 5.04 metric tonnes of CO2 equivalent in the prior year. The report notes that environmental data may not be directly comparable due to a change in operational boundaries and office relocation.

Environmental Performance

Sanofi Consumer Healthcare India Limited disclosed its waste management metrics, indicating a total waste generation of 5.08 metric tonnes in CY 2025, a decrease from 52.56 metric tonnes in CY 2024. The company achieved 100% recycling of the non-hazardous waste generated during the year. Water consumption totaled 935.22 kilolitres, with an intensity of 0.106 per rupee of turnover. The company also implemented initiatives such as energy-efficient sensors and water-saving fixtures, resulting in energy savings of up to 12% and water savings of 47.32%.

Social and Governance Metrics

The report provides detailed statistics on the company's workforce, which comprised 518 permanent employees and 79 permanent workers as of the end of the financial year. Women accounted for 18% of the permanent employee base and 4% of the permanent worker base. The company achieved 100% coverage for health and accident insurance for all permanent employees and workers. The Board of Directors included two women, representing 33% of the total six members.

The company reported one complaint regarding sexual harassment during CY 2025, which was resolved. There were zero instances of discrimination, child labour, or forced labour. The report also details the company's material responsible business conduct issues, identifying customer health and safety, data privacy, and regulatory compliance as key risks, with robust mitigation strategies in place.

Stakeholder Engagement and Operations

Sanofi Consumer Healthcare India Limited serves a diverse customer base across 29 states and 4 countries, with exports contributing 19% to total turnover. The company sourced 17% of its Active Pharmaceutical Ingredients sustainably and engaged with 100% of its value chain partners on ethical and compliance standards. The report confirms that the company has a dedicated management-level committee overseeing ESG matters, chaired by Managing Director Himanshu Bakshi.